Tunable Protease-Activatable Virus Nanonodes

We explored the unique signal integration properties of the self-assembling 60-mer protein capsid of adeno-associated virus (AAV), a clinically proven human gene therapy vector, by engineering proteolytic regulation of virus–receptor interactions such that processing of the capsid by proteases is required for infection. We find the transfer function of our engineered protease-activatable viruses (PAVs), relating the degree of proteolysis (input) to PAV activity (output), is highly nonlinear, likely due to increased polyvalency. By exploiting this dynamic polyvalency, in combination with the self-assembly properties of the virus capsid, we show that mosaic PAVs can be constructed that operate under a digital AND gate regime, where two different protease inputs are required for virus activation. These results show viruses can be engineered as signal-integrating nanoscale nodes whose functional properties are regulated by multiple proteolytic signals with easily tunable and predictable response surfaces, a promising development toward advanced control of gene delivery.

[1]  Wolfgang Jahnke and Daniel A. Erlanson Fragment-based approaches in drug discovery , 2013 .

[2]  Paul Steinbach,et al.  Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides. , 2013, Cancer research.

[3]  J. Silberg,et al.  Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity , 2012, Molecular therapy. Nucleic acids.

[4]  P. Prevelige,et al.  Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. , 2012, Nature chemistry.

[5]  Drew Endy,et al.  Engineered cell-cell communication via DNA messaging , 2012, Journal of biological engineering.

[6]  Jennifer A. Getz,et al.  Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Ramamoorthy Ramesh,et al.  Virus-based piezoelectric energy generation. , 2012, Nature nanotechnology.

[8]  D. Turk,et al.  Protease signalling: the cutting edge , 2012, EMBO Journal.

[9]  Massimo Coletta,et al.  Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. , 2012, Molecular aspects of medicine.

[10]  Yun Jung Lee,et al.  Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus Genes , 2009, Science.

[11]  M. S. Chapman,et al.  Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex. , 2009, Virology.

[12]  T. Baker,et al.  Heparin binding induces conformational changes in Adeno-associated virus serotype 2. , 2009, Journal of structural biology.

[13]  Nico A J M Sommerdijk,et al.  A virus-based single-enzyme nanoreactor. , 2007, Nature nanotechnology.

[14]  M. Francis,et al.  Self-assembling light-harvesting systems from synthetically modified tobacco mosaic virus coat proteins. , 2007, Journal of the American Chemical Society.

[15]  George M. Whitesides,et al.  Multivalency in Ligand Design , 2006 .

[16]  R. Cattaneo,et al.  Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases. , 2006, Cancer research.

[17]  Andries Zijlstra,et al.  Viral nanoparticles as tools for intravital vascular imaging , 2006, Nature Medicine.

[18]  S. Whelan,et al.  Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection , 2005, Science.

[19]  T. Weber,et al.  Altering AAV tropism with mosaic viral capsids. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Zhang,et al.  Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo , 2003, Gene Therapy.

[22]  Wendell A. Lim,et al.  Rewiring MAP Kinase Pathways Using Alternative Scaffold Assembly Mechanisms , 2003, Science.

[23]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[24]  L. Cantley,et al.  Determination of protease cleavage site motifs using mixture-based oriented peptide libraries , 2001, Nature Biotechnology.

[25]  T. Conlon,et al.  Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism , 2000, Journal of Virology.

[26]  G. Deléage,et al.  Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2 , 1999, Nature Medicine.

[27]  F. Cosset,et al.  A gene delivery system activatable by disease-associated matrix metalloproteinases. , 1997, Human gene therapy.

[28]  A. Helenius,et al.  The role of the adenovirus protease on virus entry into cells. , 1996, The EMBO journal.

[29]  M. Krečmerová,et al.  Lipases as Tools in the Synthesis of Prodrugs from Racemic 9-(2,3-Dihydroxypropyl)adenine , 2012, Molecules.

[30]  G Murphy,et al.  A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.

[31]  I. Weissman,et al.  Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus , 1988, Cell.

[32]  P. Choppin,et al.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. , 1975, Virology.